SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001099910-24-000074
Filing Date
2024-02-02
Accepted
2024-02-02 17:28:45
Documents
7
Period of Report
2024-02-02

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT akanda_6k.htm 6-K 34979
2 SECURITIES PURCHASE AGREEMENT ex1-1.htm EX-1.1 238362
3 FORM OF PRE-FUNDED WARRANT ex4-1.htm EX-4.1 110961
4 OPINION OF GOWLING WLG ex5-1.htm EX-5.1 48993
5 CLOSING OF REGISTERED DIRECT OFFERING ex99-1.htm EX-99.1 9906
6 UPDATE ON SCHEDULING POLICY IN US ex99-2.htm EX-99.2 15716
7 GRAPHIC gowlinglogo.jpg GRAPHIC 3231
  Complete submission text file 0001099910-24-000074.txt   464584
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 24592934
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)